AstraZeneca has appointed José Baselga, a prominent but controversial cancer doctor, to lead oncology research and development as part of a wider overhaul designed to get drugs to market faster.
from WSJ.com: US Business https://on.wsj.com/2QtnoUY
via IFTTT
No comments:
Post a Comment